Dimethylformamide → HCID 67152754, compound
Reaction equation
[NH4+].[Cl-].[C:3]([N:11]1[CH2:16][CH2:15][N:14]([C:17](=[O:31])[C:18]([C:20]2[C:28]3[C:23](=[N:24][C:25](C#N)=[CH:26][CH:27]=3)[NH:22][CH:21]=2)=[O:19])[C@H:13]([CH3:32])[CH2:12]1)(=[O:10])[C:4]1[CH:9]=[CH:8][CH:7]=[CH:6][CH:5]=1.[N-:33]=[N+:34]=[N-:35].[Na+].[CH3:37][N:38](C=O)C>>[C:3]([N:11]1[CH2:16][CH2:15][N:14]([C:17](=[O:31])[C:18]([C:20]2[C:28]3[C:23](=[N:24][C:25]([N:33]4[CH:37]=[N:38][N:35]=[N:34]4)=[CH:26][CH:27]=3)[NH:22][CH:21]=2)=[O:19])[C@H:13]([CH3:32])[CH2:12]1)(=[O:10])[C:4]1[CH:9]=[CH:8][CH:7]=[CH:6][CH:5]=1Participants
5
Procedure
An excess of NH4Cl (27 mg) was added into a solution of 1-(benzoyl)-3-(R)-methyl-4-[(6-cyano-7-azaindol-3-yl)-oxoacetyl]piperazine (20 mg) and NaN3 (16 mg) in DMF. The reaction was heated to reflux for 12 h. After cooling down, the mixture was concentrated under reduced pressure and the residue was purified using Shimadzu automated preparative HPLC System to give 1-benzoyl-3-(R)-methyl-4-[(6-(tetrazol-1-yl)-7-azaindol-3-yl)-oxoacetyl]piperazine (6.3 mg). MS m/z: (M+H)+ Calc'd for C22H21N8O3: 445.17; Found 3445.16. HPLC retention time: 1.42 minutes (column B); Column B: PHX-LUNA C18 4.6×30 mm.
Workup
- temperatureThe reaction was heated
- temperatureto reflux for 12 h
- temperatureAfter cooling down
- concentrationthe mixture was concentrated under reduced pressure
- customthe residue was purified
Sources & evidence
- ORD record
- ord-9e6e9d37612648bdb4e1a0138a1f96c2
- Source dataset
- uspto-grants-2009_03
- Patent number
- US07501420B2
Reaction notes
Loading…